Indigo Carmine is a Intramuscular; Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by American Regent, Inc.. The primary component is Indigotindisulfonate Sodium.
| Product ID | 0517-0375_354b6d2e-c8d2-4fc4-8505-914b64b34166 |
| NDC | 0517-0375 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Indigo Carmine |
| Generic Name | Indigo Carmine |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAMUSCULAR; INTRAVENOUS |
| Marketing Start Date | 1990-09-30 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | American Regent, Inc. |
| Substance Name | INDIGOTINDISULFONATE SODIUM |
| Active Ingredient Strength | 8 mg/mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 1990-09-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1990-09-30 |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1990-09-30 |
| Marketing End Date | 2017-03-03 |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2017-03-03 |
| Ingredient | Strength |
|---|---|
| INDIGOTINDISULFONATE SODIUM | 8 mg/mL |
| SPL SET ID: | c6f0dfc8-63b1-4bc1-96eb-3cd0c3d5d4c2 |
| Manufacturer | |
| UNII | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0517-0375 | Indigo Carmine | Indigo Carmine |
| 50090-4520 | Indigo Carmine | Indigo Carmine |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() INDIGO CARMINE 90499663 not registered Live/Pending |
Akorn Operating Company LLC 2021-01-30 |
![]() INDIGO CARMINE 75825569 2389845 Live/Registered |
Akorn, Inc. 1999-11-09 |